The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM

Clinical Nephrology

Volumn 51, Issue 3, 1999, Pages 133-140

  Vleming, L J ^a   Van Der Pijl, J W ^a   Lemkes, H H P J ^a   Westendorp, R G J ^a   Maassen, J A ^a   Daha, M R ^a   Van Es, L A ^a   Van Kooten, C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic renal failure; Gene polymorphism; Insertion deletion polymorphism; Insulin dependent diabetes mellitus; Polymerase chain reaction; Progression of disease; Renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; PATHOGENESIS; RISK ASSESSMENT;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 0033048144     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T 1983 Dabetic nephropathy in Type 1 (insulin -dependent) diabetes: an epidemiological study. Diabetologia 25: 496-501
2. Anonymous 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986
3. Baboobal K, Ravine D, Daniels J, Williams N, Holmans P, Coles GA, Williams JD 1997 Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52: 607-613
4. Barnas U, Schmidt A, Illievich A 1997 Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme polymorphism, hypertension and metabolic control. Diabetologia 40: 327-331
5. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M 1992 Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339-343
6. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH 1992 Is diabetic nephropathy an inherited complication? Kidney Int 41: 719-722
7. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F 1993 Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290: 33-40
8. Demurov LM, Christiakov DA, Chugunova LA, Shamkhalova M, Shestakova MV, Anokhin EE, Kondrat'ev L, Dedov II, Nosikin VV 1997 Polymorphism of the insertion/deletion type in the angiotensin-converting enzyme gene in normal subjects and among patients with vascular complications. Mol Biol 31: 59-62
9. Forsblom CM, Groop P, Ekstrand A, Groop LC 1992 Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ 305: 1051-1053
10. Fujisawa T, Ikegami H, Kawagachi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T 1998 Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41: 47-53
11. Gaciong Z, Religa P, Placha G, Paczek L, Rell K, Perkowska A, Lao M 1995 High frequency of D allele of angiotensin-converting enzyme (ACE) among renal allograft recipients. J Am Soc Nephrol 6: 721A (Abstract)
12. Hallab M, Berrut G, Bouhanick B, Bled F, Suraniti S, Girault A, Fressinaud P, Marre M 1992 Increase of activity of angiotensin-converting enzyme in insulin-dependent diabetic patients with permanent microalbuminuria. Arch Mal Coeur Vaiss 85: 1185-1188
13. Harden PN, Geddes C. Rowe PA, Boulton-Jones JD, Briggs JD, Junor BJR, Rodger RSCR, McMillan M, Connell JMC, Jardine AG 1995a ACE gene polymorphism and progression of renal disease. J Am Soc Nephrol 390A (Abstract)
14. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RS, Junor BJ. Briggs JD, Connell JM, Jardine AG 1995b Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542
15. Hunley TE, Julian BA, Phillips III JA, Summar ML, Yoshida H, Hom RG, Brown NJ, Fogo A, Ichikawa I, Kon V 1996 Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Im 49: 571-577
16. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma AM 1998 Association between the angitensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: A methodological appraisal and systematic review. J Am Soc Nephrol 9: 1653-1663
17. Lewis KJ, Hunsicker LG, Bain RP, Rohde RD 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456-1462
18. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F 1994 Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388
19. Marre M, Jeunemaitre X, Gallois Y 1997 Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99: 1585-1595
20. McLaughlin KJ, Harden PN, Ueda S, Boulton-Jones M, Connell JMC, Jardine AG 1996 The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 28: 912-915
21. Ogura M, Yoshidu H, Kawamura T, Hamagachi A, Miyazaki Y, Mitarai T, Okada T, Eto T, Kitajima T, Sakai O 1995 The impact of the ACE gene polymorphism on the slowly progressive IgA nephropathy may be linked to the glomerular size. J Am Soc Nephrol 6: 398A (Abstract)
22. Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L. Poirier O, Cambien F 1996a Effect of deletion polymorphism of angiotensin convening enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Brit Med J 313: 591-594
23. Parving HH, Osterby R, Anderson PW, Hsueh WA 1996b Diabetic nephropathy. In: Brenner BM: The Kidney. Saunders, Philadelphia, 1864
24. Parving HH, Tarnow L. Rossing P 1996c Genetics of diabetic nephropathy. J Am Soc Nephrol 7: 2509-2517
25. Pei Y, Scholey J, Thai K, Suzaki M, Caffran D 1997 Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in caucasian patients. J Clin Invest 100: 814-820
26. Quinn M, Angelico ML, Warram JH, Krolewski AS 1996 Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945
27. Reddi AS, Camerini-Davalos RA 1990 Diabetic nephropathy. An update. Arch Intern Med 150: 31-43
28. Rigat B, Hubert C, Alhenc-Gelas F, Combien F, Corvol P, Soubrier F 1990 An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
29. Rigat B, Hubert C, Corvol P, Soubrier F 1992 PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20: 1433
30. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL 1996 A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 708-712
31. Schmidt A, Kiener HP, Bamas U, Arias I, Illievich A, Auinger M, Graninger W, Kaider A, Mayer G 1996 Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 7: 314-317
32. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, Clarkson AR, Ponticelli C, Campise M, Mayer G, Ganten D, Ritz E 1995 No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 26: 727-731
33. Schmidt S, Strojek K, Greszczak W, Bergis K, Ritz E, Diabetic Nephropathy Study Group 1997 Excess of DD homozygotes in haemodialysed patients with type II diabetes. Nephrol Dial Transplant 12: 427-429
34. Seaquist ER, Goetz FC, Rich S, Barbosa J 1989 Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165
35. Shanmugam V, Sell KW, Saha BK 1993 Mistyping ACE heterozygotes. PCR Methods Appl 3: 120-121
36. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R 1997 The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 15: 1579-1592
37. Tarnow L, Gluud C, Parving HH 1998 Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 13: 1125-1130
38. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F 1992 Evidence from combined segregation and linkage analysis, that a variant in the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197-205
39. van Essen GG, Rensma PL, de Zeeaw D, Sluiter WJ, Scheffer H, Apperloo AJ, de Jong PE 1996 Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347: 94-95
40. Yorioka T, Shuehino T, Yasuoka N, Hashimoto K, Kawada M 1995 Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 44: 80-85
41. Yoshida H, Mitarai T, Kawamura T. Kitajima T, Miyazaki Y, Nagasawa R, Kawagachi Y, Kubo H, Ichikawa I, Sakai O 1995 Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsive-ness of IgA nephropathy. J Clin Invest 96: 2162-2169
42. Yashida H, Kon V, Ichikawa I 1996a Polymorphisms of the renin-angiolensin system genes in progressive renal diseases. Kidney Int 50: 732-744
43. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamagachi A, Kubo H. Kawagachi Y, Kon V, Matsuoka K, Ichikawa I, Sakai O 1996h Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50: 657-664